PGR and ovarian cancer: There were three stratified subgroups about source regions of included studies, a pooled HR was 0.69 (n = 16, 95% CI = 0.55 to 0.88, P = 0.002, I2 = 73.4%) in European population, indicating that progesterone receptor positivity exerted favorable influence on OS among these ovarian cancer patients.